What’s New with PARP Inhibitors and Ovarian Cancer?
PARP inhibitors have revolutionized ovarian cancer treatment, but recent updates to the FDA-approved indications have caused confusion and raised questions for patients. So what do these changes mean? Dr. Thomas Herzog, Deputy Director of the University of Cincinnati Cancer Center, discusses the current landscape of PARP inhibitors for ovarian cancer and what it means for […]
Part II: DCIS Research: De-escalating the Fear of Recurrence
Ductal carcinoma in situ (DCIS) can be treated with surgery, or with Active Monitoring for low-risk DCIS. Chemotherapy is not needed, although sometimes radiation or hormone therapy are suggested. Most DCIS never develops into an invasive cancer. In part 2 of the DCIS webinar series, we discuss where research is taking us. For those who […]
Report Back from San Antonio Breast Cancer Symposium (SABCS) 2023: Spotlight on the Latest in MBC
We are thrilled to have Dr. Timothy Pluard, director of the Saint Luke’s Koontz Center for Advanced Breast Cancer, explain the recent research released at the annual San Antonio Breast Cancer Symposium (SABCS), 2023. Watch this webinar to gain a better understanding of what all the new data means to you and hear the answers […]
Why are Breast Cancers More Aggressive in Black Women?
There are striking disparities in survival rates between Black and white breast cancer patients. Our guest speakers, Christine Ambrosone, PhD, and Song Yao, MD, PhD, have led a team that has done extensive research to understand the causes of why certain cancers are more aggressive in Black women. They have developed a hypothesis that the […]
What’s the Latest in Clear Cell Ovarian Cancer?
The understanding of clear cell ovarian cancer is evolving. If you’re diagnosed with clear cell ovarian cancer and eager for information specific to your subtype, we’ve got you covered! Join Dr. Jubilee Brown, Professor and Director of Gynecologic Oncology at Levine Cancer Institute, as she discusses current treatment options and any promising advances. Come with […]
Report Back from ASCO: What’s the Latest News in Metastatic Breast Cancer?
Join Dr. Sherry Shen, breast oncologist from Memorial Sloan Kettering Cancer Center, as she breaks down the recent research from the American Society of Clinical Oncology(ASCO), 2023 Annual Meeting. She will present what all the new data means to you and answer questions that you may have. https://www.youtube.com/watch?v=UPZIKLJF9qE
Report Back from SGO 2023: What’s New in Ovarian Cancer?
Curious about what’s new in ovarian cancer research? Join Dr. Dineo Khabele, Mitchell & Elaine Yanow Professor and Chair of the Department of Obstetrics & Gynecology at Washington University School of Medicine, as she shares the latest updates from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Khabele will also highlight […]
Report Back from SGO: What’s New in Uterine Cancer?
Join Dr. Alex Buckley, Assistant Professor, Division of Gynecologic Oncology at Columbia University Irving Medical Center, as he provides a comprehensive update from the Society of Gynecologic Oncology (SGO) Annual Meeting on Women’s Cancer. Dr. Buckley breaks down the research presented at the conference, discuss new developments, and address your questions. Key Takeaways from Webinar […]
Let’s Talk About It: Triple-Negative Breast Cancer – Cutting-Edge Research on TNBC
Researchers from the University of Arizona have developed a drug compound that appears to stop cancer cell growth in what’s known as triple-negative breast cancer. The drug, which has not yet been tested in humans, has been shown to eliminate tumors in mice, with little to no effect on normal healthy cells, making it potentially […]
